dm+d
111165009
Articles
Azathioprine monitoring
13 July 2021
Medicine Compliance Aid Stability
Imuran
Aspen
Aspen
Imuran
Tablets f/c 25mg, 50mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light. Airtight container
25 October 2022
Lactation Safety Information
In transplantation
In transplantation
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020
For rheumatoid arthritis
For rheumatoid arthritis
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020
For eczema
For eczema
Topical eczema preparation / corticosteroid if appropriate
Unlicensed indication in the UK
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
Monitor for signs of infection and immunosuppression, and, if high dose used, infant blood counts
24 September 2020
For inflammatory bowel disease
For inflammatory bowel disease
See summary
Moderate level of published evidence of use in breastfeeding
Small amounts of active metabolite, 6-mercaptopurine, in breast milk
If high dose used, monitor infant blood counts
24 September 2020